{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:51:44Z","timestamp":1791150704658,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.leukres.2006.02.008","type":"journal-article","created":{"date-parts":[[2006,3,15]],"date-time":"2006-03-15T12:41:16Z","timestamp":1142426476000},"page":"1235-1239","source":"Crossref","is-referenced-by-count":26,"title":["Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia"],"prefix":"10.1016","volume":"30","author":[{"given":"Felipe","family":"Lorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Monma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kuwagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Usui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Shiku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2006.02.008_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/jcp.38.11.1201","article-title":"Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications","volume":"38","author":"Jacobs","year":"1985","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.leukres.2006.02.008_bib2","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1182\/blood.V81.11.3022.3022","article-title":"Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia","volume":"81","author":"Sugimoto","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.02.008_bib3","first-page":"206","article-title":"Ras and myelodysplasia: lessons from the last decade","volume":"33","author":"Parker","year":"1996","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2006.02.008_bib4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.leu.2401044","article-title":"RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up","volume":"12","author":"Padua","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.02.008_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1073\/pnas.87.4.1377","article-title":"FMS mutations in myelodysplastic, leukemic, and normal subjects","volume":"87","author":"Ridge","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.02.008_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0268-960X(03)00024-9","article-title":"Receptor tyrosine kinases in normal and malignant haematopoiesis","volume":"17","author":"Reilly","year":"2003","journal-title":"Blood Rev"},{"key":"10.1016\/j.leukres.2006.02.008_bib7","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1365-2141.1999.01449.x","article-title":"c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia","volume":"105","author":"Gari","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.02.008_bib8","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias","volume":"121","author":"Care","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.02.008_bib9","first-page":"920","article-title":"KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication","volume":"89","author":"Beghini","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2006.02.008_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/sj.leu.2403803","article-title":"Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22)","volume":"19","author":"Nanri","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.02.008_bib11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1073\/pnas.0408831102","article-title":"AML1-ETO and C-KIT mutation\/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.02.008_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2006.02.008_bib13","first-page":"372","article-title":"Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype","volume":"71","author":"Nishii","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2006.02.008_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0609.2005.00543.x","article-title":"Molecular analysis of PDGFRalpha\/beta genes in core binding factor leukemia with eosinophilia","volume":"76","author":"Monma","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2006.02.008_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/327430a0","article-title":"A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome","volume":"327","author":"Hirai","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2006.02.008_bib16","first-page":"609","article-title":"Mechanisms of ras mutation in myelodysplastic syndrome","volume":"4","author":"Yunis","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2006.02.008_bib17","first-page":"865","article-title":"NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q)","volume":"89","author":"Fidler","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2006.02.008_bib18","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/cncr.20440","article-title":"Internal tandem duplication of fms-like tyrosine kinase 3 is associated with poor outcome in patients with myelodysplastic syndrome","volume":"101","author":"Shih","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2006.02.008_bib19","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-04-1932","article-title":"Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia","volume":"11","author":"Shih","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2006.02.008_bib20","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.leukres.2006.02.008_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0145-2126(88)90050-1","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"12","author":"Butterfield","year":"1988","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.02.008_bib22","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2006.02.008_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0889-8588(05)70303-8","article-title":"A proposed classification of mastocytosis incorporating molecular genetics","volume":"14","author":"Longley","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2006.02.008_bib24","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1172\/JCI116761","article-title":"Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product","volume":"92","author":"Furitsu","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.leukres.2006.02.008_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/sj.leu.2402341","article-title":"Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia-potential clinical significance","volume":"16","author":"Inokuchi","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2006.02.008_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","article-title":"C-kit mutations in core binding factor leukemias","volume":"95","author":"Beghini","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.02.008_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1182\/blood.V92.2.701","article-title":"c-kit activating mutations and mast cell proliferation in human leukemia","volume":"92","author":"Beghini","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2006.02.008_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0145-2126(02)00041-3","article-title":"Detection of c-kit point mutation Asp-816 \u2192 Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia","volume":"26","author":"Sotlar","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.02.008_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0145-2126(02)00303-X","article-title":"Flt-3 and c-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease","volume":"27","author":"Pardanani","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2006.02.008_bib30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.thj.6200348","article-title":"Chronic myelogenous leukemia with acquired c-kit activating mutation and transient bone marrow mastocytosis","volume":"5","author":"Cairoli","year":"2004","journal-title":"Hematol J"},{"key":"10.1016\/j.leukres.2006.02.008_bib31","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.leukres.2006.02.008_bib32","doi-asserted-by":"crossref","first-page":"922a","DOI":"10.1182\/blood.V106.11.3297.3297","article-title":"Distinct characteristics of t(8;21) acute myeloid leukemia with active KIT mutation","volume":"106","author":"Lorenzo","year":"2005","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260600066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521260600066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,24]],"date-time":"2021-07-24T22:41:47Z","timestamp":1627166507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521260600066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S014521260600066X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2006.02.008","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}